Initial Workup of Neutropenia
The initial step in the workup of a patient with neutropenia should include a thorough history, physical examination, blood cultures, and complete blood count with differential to determine the severity, chronicity, and potential causes of the neutropenia. 1
Definition and Risk Stratification
Neutropenia is defined as an absolute neutrophil count (ANC) less than 1,500 cells/μL and can be categorized by severity:
- Mild: 1,000-1,500 cells/μL
- Moderate: 500-1,000 cells/μL
- Severe: <500 cells/μL 2
The risk of infection increases significantly with:
- ANC <500 cells/μL
- Prolonged duration (>7 days)
- Rapid decline in neutrophil count 1
Initial Diagnostic Approach
Step 1: Determine Severity and Risk
- Calculate the absolute neutrophil count
- Assess for signs of infection (fever, localized symptoms)
- Evaluate risk factors using the MASCC score (for febrile neutropenia):
- Score ≥21 indicates low risk (6% complication rate)
- Score <21 indicates high risk 3
Step 2: Immediate Diagnostic Tests
- Complete blood count with differential
- Blood cultures (at least 2 sets)
- Comprehensive metabolic panel
- Chest radiograph
- Additional cultures from suspected sites of infection 1, 3
Step 3: Evaluate for Underlying Causes
- Medication history (chemotherapy, antibiotics, anticonvulsants)
- Recent infections
- Underlying hematologic disorders
- Autoimmune conditions
- Family history of neutropenia 4
Management Based on Presentation
For Febrile Neutropenia (Medical Emergency)
- Immediate blood cultures and cultures from suspected infection sites
- Prompt initiation of broad-spectrum antibiotics (within 2 hours)
- Monotherapy with anti-pseudomonal β-lactam (cefepime, meropenem, or piperacillin-tazobactam)
- Add vancomycin only for specific indications (catheter infection, MRSA colonization, skin/soft tissue infection) 3
For Afebrile Neutropenia
- Determine chronicity (acute vs. chronic)
- For chronic neutropenia (>3 months), consider:
- Bone marrow aspiration and biopsy
- Cytogenetic analysis
- Flow cytometry
- Genetic testing for congenital neutropenias 4
Special Considerations
Cancer Patients
- Risk stratify based on anticipated duration of neutropenia:
- Low risk: <7 days of neutropenia
- High risk: >10 days of neutropenia or profound neutropenia (ANC <100 cells/μL)
- Consider prophylactic antibiotics (fluoroquinolones) for high-risk patients 1
Congenital Neutropenias
- Bone marrow examination
- Genetic testing for known mutations
- Consider G-CSF therapy based on severity and infection history 1
Common Pitfalls to Avoid
- Delayed evaluation of febrile neutropenia - This is a medical emergency requiring immediate intervention
- Failure to obtain adequate cultures before starting antibiotics
- Inappropriate use of growth factors without clear indications
- Missing drug-induced neutropenia - Always review medication history
- Overlooking chronic neutropenia that may indicate underlying hematologic disorders 3
Follow-up Recommendations
- For mild, asymptomatic neutropenia: Serial CBCs to monitor trends
- For moderate neutropenia: More frequent monitoring and consideration of bone marrow evaluation if persistent
- For severe neutropenia: Consider G-CSF therapy, especially with recurrent infections 1
The workup of neutropenia requires a systematic approach focusing on identifying the underlying cause while simultaneously assessing infection risk. Early recognition and appropriate management are crucial to prevent serious complications, particularly in patients with severe neutropenia.